AVRA Medical Robotics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of AVRA Medical Robotics generated cash of -$1,435,841, which is less than the previous year. Cash used in financing activities reached the amount of $5,381,431 last year. Net change in cash is therefore $945,590.
Cash Flow
| 2016 | -211.94K | -43.54K | 503.61K |
|---|---|---|---|
| 2017 | -446.85K | -4.17K | 655.38K |
| 2018 | -443.28K | -23.56K | 50K |
| 2019 | -424.10K | -50.12K | 466.98K |
| 2020 | -90.54K | -44K | 266.77K |
| 2021 | -363.03K | 38.15K | 569.94K |
| 2022 | -1.43M | -3M | 5.38M |
AVMR Cash Flow Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 405.77K | 160.70K | 28.47K | 35.71K | 452.57K | 248.21K | 100 |
Operating activities | |||||||
Net income | -2.21M | -1.48M | -1.12M | -3.38M | -960.32K | -1.03M | -484.98K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 9.14K | 18.78K | 37.43K | 37.70K | 19.46K | 789 | 0 |
Stock-based compensation expense | 865.46K | 767.23K | 434.18K | 1.07M | 187.06K | 265.90K | 128.08K |
| Deferred income tax benefit | 865.46K | 767.23K | 434.18K | 1.07M | 187.06K | 265.90K | 128.08K |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -91.05K | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -1.43M | -363.03K | -90.54K | -424.10K | -443.28K | -446.85K | -211.94K |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | -40K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | -4K | -50.12K | -23.56K | -4.17K | -43.54K |
Acquisitions Net | 0 | 38.15K | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -3M | 38.15K | -44K | -50.12K | -23.56K | -4.17K | -43.54K |
Financing activities | |||||||
Common Stock Issued | 1.52M | 583.05K | 194.84K | 0 | 20K | 677.26K | 1.9K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -26K | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -65K | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.38M | 569.94K | 266.77K | 466.98K | 50K | 655.38K | 503.61K |
Net Change In Cash | 945.59K | 245.06K | 132.23K | -7.24K | -416.85K | 204.35K | 248.11K |
Cash at end of period | 1.35M | 405.77K | 160.70K | 28.47K | 35.71K | 452.57K | 248.21K |
| Data source | Data source | Data source | Data source | Data source | Data source |